ArticleFrontiers in veterinary science2025
Maternal and protective antibody responses to E2 subunit and C-strain classical swine fever vaccines in piglets: a comparative analysis.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Classical swine fever (CSF), caused by the classical swine fever virus (CSFV), is an acute and highly contagious disease affecting swine. In clinical settings, the C- strain vaccine and the E2 subunit vaccine are commonly employed for the prevention and management of the condition. This study monitored the antibody levels of pigs immunized with different CSF vaccines under field conditions, comparing the effects of the classical swine fever virus E2 subunit vaccine and the C-strain vaccine on the duration of maternal antibody maintenance and protective efficacy in fattening pig herds. In the case of sows vaccinated with the E2 subunit vaccine, effective maternal antibodies can be maintained for up to 75 days postpartum, thereby allowing the first vaccination of their piglets to be delayed until 75 days of age. With regard to the immunization of fattening pigs, the E2 subunit vaccine has been demonstrated to confer protection for a period of time sufficient to allow the animals to reach market weight following a single administration of the vaccine. The findings demonstrate that, in comparison with the C-strain vaccine, the E2 subunit vaccine has the capacity to sustain maternal antibodies and protective antibodies over a more protracted period without the necessity for booster immunizations. This translates to a reduction in vaccination frequency and dosage requirements in commercial production. This study provides a theoretical foundation for the optimization of immunization processes within clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.